Some knowledge is inherited.
Some must be validated.
For centuries, Traditional Chinese Medicine has relied on observation, experience, and trust built across generations. But today’s research environment asks for something more: measurable outcomes, reproducibility, and scalable biological validation.
At Anhui University of Chinese Medicine, researchers weren’t trying to modernize tradition for the sake of modernization. They were working to build something stronger, a bridge between centuries of medical wisdom and the precision standards required in contemporary science.
Their ambition was clear: develop a high-standard, organoid-based Bio-Functional Evaluation Platform capable of compound screening, efficacy validation, and advanced in vitro modeling tailored specifically to the complexity of TCM research.
The obstacle wasn’t knowledge.
It was the tools supporting it.
Manual workflows slowed throughput. Variability limited reproducibility. Conventional drug discovery tools weren’t designed for multi-component TCM formulations. The science was ready to evolve, but the systems weren’t.
To move forward, the university needed more than a new instrument.
They needed technology that could adapt to their research model, and a partner willing to build alongside them.
Designing around the research, not the equipment
The collaboration began with listening.
Where did workflow friction occur?
What level of automation would meaningfully accelerate organoid screening?
How could precision be improved without compromising biological complexity?
Through hands-on consultation, scenario-based workshops, and technical evaluation, the solution centered on the Explorer™ G3 system, not as a standalone device, but as the foundation of an automated organoid workflow built for consistency and scale.
Its differentiation wasn’t just in capability, but in alignment:
- Automated liquid handling to increase throughput and reduce manual variability
- Dispensing suited for complex compound matrices
- Flexible configuration to accommodate customized TCM evaluation protocols
- Scalability to support both exploratory research and standardized validation
Implementation support extended beyond installation. Documentation and procurement were streamlined. Training focused on integration, ensuring the system became part of a daily research rhythm, not a disruption to it.
This wasn’t about placing technology.
It was about enabling progress.
Setting a New Standard
The milestone is notable: the first Explorer G3 system placed within a Traditional Chinese Medicine research setting.
But the true impact goes deeper.
The university now operates with greater automation, and more efficient screening workflows. Organoid modeling supports higher scientific standards. Biological validation is more consistent and scalable.
And beyond one laboratory, a precedent has been established.
This platform demonstrates that advanced organoid technologies can elevate TCM research without diminishing its foundation. It offers a replicable model for institutions seeking to integrate traditional medical insight with globally recognized scientific rigor.
Modernization does not erase history.
It strengthens it.
The future tradition deserves
Tradition carries authority.
Science carries proof.
When brought together with intention, they don’t compete. They compound.
At Anhui University of Chinese Medicine, centuries of wisdom now move forward with automation, consistency, and confidence, not to rewrite history, but to validate it. And thanks to technology tailored to their goals and support that stayed with them every step of the way, they can now focus on insights instead of obstacles.
Because the future of research isn’t about choosing between legacy and innovation.
It’s about building the bridge that allows both to thrive.
For research use only. Not for use in diagnostic procedures.
